Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Receivables (2016 - 2025)

Historic Receivables for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $63.0 million.

  • AtriCure's Receivables rose 1469.89% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year increase of 1469.89%. This contributed to the annual value of $60.3 million for FY2024, which is 1492.92% up from last year.
  • According to the latest figures from Q3 2025, AtriCure's Receivables is $63.0 million, which was up 1469.89% from $66.0 million recorded in Q2 2025.
  • AtriCure's Receivables' 5-year high stood at $66.0 million during Q2 2025, with a 5-year trough of $29.7 million in Q1 2021.
  • In the last 5 years, AtriCure's Receivables had a median value of $48.4 million in 2023 and averaged $48.1 million.
  • In the last 5 years, AtriCure's Receivables surged by 4780.27% in 2021 and then skyrocketed by 656.15% in 2024.
  • Quarter analysis of 5 years shows AtriCure's Receivables stood at $33.0 million in 2021, then rose by 29.29% to $42.7 million in 2022, then rose by 22.97% to $52.5 million in 2023, then increased by 14.93% to $60.3 million in 2024, then rose by 4.38% to $63.0 million in 2025.
  • Its Receivables was $63.0 million in Q3 2025, compared to $66.0 million in Q2 2025 and $63.3 million in Q1 2025.